Search Ontology:
ChEBI
sulfasalazine
- Term ID
- CHEBI:9334
- Synonyms
-
- 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid
- 2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid
- 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid
- 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene
- 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
- 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
- 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
- Azulfidine
- Salazosulfapiridina
- Salazosulfapyridine
- Salazosulfapyridinum
- Salicylazosulfapyridine
- Sulfasalazina
- Sulfasalazine
- Sulfasalazinum
- Definition
- An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
- References
-
- beilstein:356241
- cas:599-79-1
- drugbank:DB00795
- gmelin:2666050
- kegg.compound:C07316
- kegg.drug:D00448
- patent:US2396145
- pdb-ccd:SAS
- pubmed:11362329
- pubmed:11485124
- pubmed:11587223
- pubmed:14981898
- pubmed:15248210
- pubmed:16322111
- pubmed:17386570
- pubmed:2434548
- pubmed:7720170
- reaxys:8132868
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from sulfasalazine
Phenotype where environments contain sulfasalazine
Phenotype modified by environments containing sulfasalazine
Phenotype affecting sulfasalazine
Human Disease Model